Galderma Labs Seeks OK Of Award Over Botox-Like Treatment
Galderma Laboratories has asked a Texas federal court to enforce an arbitral award in its trade secrets dispute with Ipsen Biopharm over an application seeking U.S. government approval of a Botox-like...To view the full article, register now.
Already a subscriber? Click here to view full article